NEW2026 · Text us +1 272-529-4722
Prescription prenatal vitamin softgel with folic acid, iron, and DHA, taken once daily before, during, and after pregnancy.
Reviewed by:
Dr. Steve Malen, PharmD
Dr. Steven Blikstein, PharmD
Strength
How would you like to get this medication?
Choose a strength and quantity to continue.
Vitafol is a prescription prenatal vitamin and mineral supplement, not an FDA-approved drug, intended to support nutritional needs before conception, during pregnancy, and while breastfeeding. Each softgel provides folic acid, iron, vitamin B12, and other essential vitamins and minerals, along with DHA (an omega-3 fatty acid) to support fetal development. The typical dose is one softgel by mouth daily, or as directed by a physician. Because it contains iron, it should be kept out of reach of children, as accidental overdose of iron-containing products can be dangerous. Discuss any allergies, including soy or fish, and any other supplements or medications you take with your provider before starting.
Complete a health screening
A short questionnaire about your health history and current symptoms — takes about 2 minutes.
Provider reviews your answers
A licensed provider reviews your screening answers, typically within 24 hours.
Prescription fulfilled
If approved, your Rx is sent to Invictus Pharmacy and you're notified by text or email. Free nationwide shipping.
Vitafol is a nutritional supplement, not an FDA-approved medication, so it is regulated differently than prescription drugs. It is generally well tolerated, though some people experience mild nausea, constipation, or stomach upset, especially from the iron content; taking it with food can help.
Important precautions:
Clomiphene citrate is a powerful, nonsteroidal Selective Estrogen Receptor Modulator (SERM) used as a first-line, orally administered therapy for treating ovulatory dysfunction in women desiring pregnancy. It works by selectively modulating estrogen receptors to stimulate the hypothalamic–pituitary–ovarian (HPO) axis, leading to follicular growth and subsequent ovulation. Since its FDA approval in 1967, it has been widely used and is also employed off-label in men with secondary hypogonadism.
